Fulton Breakefield Broenniman LLC Eli Lilly & CO Transaction History

Fulton Breakefield Broenniman LLC

$1.41 Billion
Q3 2024

A detailed history of Fulton Breakefield Broenniman LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 42,715 shares of LLY stock, worth $31.9 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares

42,715

Previous 43,680 2.21%

Holding current value

$31.9 Million

Previous $39.5 Million 4.31%

% of portfolio

2.69%

Previous 2.97%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $745,115 - $926,419	-965 Reduced 2.21%	42,715 $37.8 Million
Q2 2024 Aug 07, 2024	SELL	$724.87 - $909.04 $179,767 - $225,441	-248 Reduced 0.56%	43,680 $39.5 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $7.14 Million - $9.55 Million	-12,056 Reduced 21.53%	43,928 $34.2 Million
Q4 2023 Feb 02, 2024	SELL	$525.19 - $619.13 $342,949 - $404,291	-653 Reduced 1.15%	55,984 $32.6 Million
Q3 2023 Oct 20, 2023	SELL	$434.7 - $599.3 $350,368 - $483,035	-806 Reduced 1.4%	56,637 $30.4 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $3.94 Million - $5.27 Million	-11,233 Reduced 16.36%	57,443 $26.9 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $327,714 - $384,885	-1,055 Reduced 1.51%	68,676 $23.6 Million
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $36,013 - $41,963	112 Added 0.16%	69,731 $25.5 Million
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $3.19 Million - $3.63 Million	-10,748 Reduced 13.37%	69,619 $22.5 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $2.36 Million - $2.77 Million	-8,476 Reduced 9.54%	80,367 $26.1 Million
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $278,107 - $345,617	1,185 Added 1.35%	88,843 $25.4 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $327,156 - $406,003	1,455 Added 1.69%	87,658 $24.2 Million
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $122,101 - $150,263	-551 Reduced 0.64%	86,203 $19.9 Million
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $7.45 Million - $9.63 Million	-41,242 Reduced 32.22%	86,754 $19.9 Million
Q1 2021 Apr 09, 2021	BUY	$164.32 - $212.72 $3.73 Million - $4.83 Million	22,721 Added 21.58%	127,996 $23.9 Million
Q4 2020 Jan 14, 2021	SELL	$130.46 - $172.63 $2.01 Million - $2.66 Million	-15,425 Reduced 12.78%	105,275 $17.8 Million
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $3.57 Million - $4.13 Million	24,443 Added 25.39%	120,700 $17.9 Million
Q2 2020 Jul 10, 2020	BUY	$136.42 - $164.18 $511,574 - $615,675	3,750 Added 4.05%	96,257 $15.8 Million
Q1 2020 Apr 10, 2020	BUY	$119.05 - $147.35 $360,602 - $446,323	3,029 Added 3.39%	92,507 $12.8 Million
Q4 2019 Jan 14, 2020	BUY	$106.92 - $132.43 $112,800 - $139,713	1,055 Added 1.19%	89,478 $11.8 Million
Q3 2019 Oct 17, 2019	BUY	$106.79 - $116.16 $9.44 Million - $10.3 Million	88,423 New	88,423 $9.89 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Account

Fulton Breakefield Broenniman LLC Eli Lilly & CO Transaction History